Patient Guide: Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 198 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04949256
Status: ACTIVE_NOT_RECRUITING
Condition: Metastatic Esophageal Squamous Cell Carcinoma
Phase: PHASE3

Find a Study Location Near You

This study is available at 198 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Duarte, California
  • Washington D.C., District of Columbia
  • Louisville, Kentucky
  • • And 195 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily